PL378543A1 - Dosage form having a saccharide matrix - Google Patents

Dosage form having a saccharide matrix

Info

Publication number
PL378543A1
PL378543A1 PL378543A PL37854304A PL378543A1 PL 378543 A1 PL378543 A1 PL 378543A1 PL 378543 A PL378543 A PL 378543A PL 37854304 A PL37854304 A PL 37854304A PL 378543 A1 PL378543 A1 PL 378543A1
Authority
PL
Poland
Prior art keywords
dosage form
saccharide matrix
saccharide
matrix
dosage
Prior art date
Application number
PL378543A
Other languages
Polish (pl)
Other versions
PL210707B1 (en
Inventor
Christian Gauguin Houghton
Annette Römmelmayer Lundegaard
Original Assignee
Alk-Abello A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk-Abello A/S filed Critical Alk-Abello A/S
Publication of PL378543A1 publication Critical patent/PL378543A1/en
Publication of PL210707B1 publication Critical patent/PL210707B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL378543A 2003-02-28 2004-02-24 Dosage form having a saccharide matrix PL210707B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300318 2003-02-28
US46538303P 2003-04-25 2003-04-25

Publications (2)

Publication Number Publication Date
PL378543A1 true PL378543A1 (en) 2006-05-02
PL210707B1 PL210707B1 (en) 2012-02-29

Family

ID=32929063

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378543A PL210707B1 (en) 2003-02-28 2004-02-24 Dosage form having a saccharide matrix

Country Status (9)

Country Link
EP (1) EP1599185A1 (en)
JP (1) JP4688787B2 (en)
KR (1) KR101136573B1 (en)
AU (1) AU2004216559B2 (en)
CA (1) CA2516291C (en)
HK (1) HK1089083A1 (en)
MX (1) MXPA05009079A (en)
PL (1) PL210707B1 (en)
WO (1) WO2004075875A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
PL2493457T3 (en) * 2009-10-30 2018-01-31 Ix Biopharma Ltd Fast dissolving solid dosage form
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
ES2643087T3 (en) 2010-03-29 2017-11-21 Ferring B.V. Quick Dissolve Pharmaceutical Composition
JP5800527B2 (en) * 2010-03-30 2015-10-28 日東電工株式会社 Stabilized pharmaceutical composition, stabilized pharmaceutical composition solution preparation, film-form preparation and method for producing film-form preparation
WO2012059724A1 (en) * 2010-11-04 2012-05-10 Norgine Bv Formulations comprising polyethylene glycol
JP2012240975A (en) * 2011-05-20 2012-12-10 Nitto Denko Corp Pharmaceutical composition and jerry-form preparation
JP2012240978A (en) * 2011-05-20 2012-12-10 Nitto Denko Corp Pharmaceutical composition and gelatinous preparation
WO2013037708A1 (en) 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
EP3482771B1 (en) * 2013-03-14 2023-01-18 Société des Produits Nestlé S.A. Manufacture of peanut formulations for oral desensitization
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
GB2545880A (en) 2015-10-20 2017-07-05 Glide Pharmaceutical Tech Ltd Solid formulation
JP2021504327A (en) * 2017-11-27 2021-02-15 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． Lyophilized multi-particle solid formulation
WO2019146777A1 (en) * 2018-01-29 2019-08-01 株式会社リタファーマ Pharmaceutical formulation and production method for same
CN113966229A (en) 2019-05-10 2022-01-21 爱沐疗法公司 Method for improving the quality of life of peanut allergic patients
CN116891827B (en) * 2023-09-08 2024-01-30 山东康华生物医疗科技股份有限公司 NK cell activity activation system

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD107208A1 (en) 1973-06-04 1974-07-20
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
FR2609895B1 (en) 1987-01-28 1991-06-28 Bruttmann Georges NEW GALENIC FORMS OF ALLERGENS FOR PER- AND SUB-LINGUAL ADMINISTRATION
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5558880A (en) 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
US6337082B1 (en) 1991-10-25 2002-01-08 Biovail Tech Ltd Saccharide-based matrix
US5343762A (en) 1992-10-05 1994-09-06 Rosemount Inc. Vortex flowmeter
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
JPH08508247A (en) * 1993-03-11 1996-09-03 セクレテック，インク． Polymeric mucoadhesives in the transport of immunogen to mucosal surfaces
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
US20020197321A1 (en) * 1997-10-27 2002-12-26 Harry Seager Solid dispersing vaccine composition for oral delivery
ATE408690T1 (en) 1998-03-16 2008-10-15 Alk Abello As MUTATED RECOMBINANT ALLERGEN
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
FR2790387B1 (en) 1999-03-01 2001-05-18 Prographarm Laboratoires ORODISPERSIBLE TABLET HAVING LOW FRIABILITY AND PROCESS FOR THE PREPARATION THEREOF
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
FR2791569B1 (en) 1999-03-31 2003-05-09 Pf Medicament ISOTROPIC FAST DISSOLVING ISOTROPIC MICROPOROUS COMPOSITION OR STRUCTURE FOR PHARMACEUTICAL, VETERINARY, DIETETIC, FOOD OR COSMETIC USE AND PROCESS FOR OBTAINING THE SAME
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
PT1212045T (en) * 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd A vaccine composition and method of using the same
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
DE19951970A1 (en) * 1999-10-28 2001-05-03 Bionetworks Gmbh Medicines for tolerance induction
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
JP2004521618A (en) 2000-11-16 2004-07-22 アルカベロ アクチェセルスカプ Novel mutant allergen
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
ITMI20010571A1 (en) * 2001-03-19 2002-09-19 Grisotech S A TRANS-MUCOSAL ABSORBABLE VACCINES
CN1668737A (en) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 Recombined Bet-V-1 allergen mutants, its preparation method and equipment

Also Published As

Publication number Publication date
KR20050105491A (en) 2005-11-04
WO2004075875A1 (en) 2004-09-10
JP2006519187A (en) 2006-08-24
CA2516291C (en) 2012-02-14
HK1089083A1 (en) 2006-11-24
CA2516291A1 (en) 2004-09-10
EP1599185A1 (en) 2005-11-30
PL210707B1 (en) 2012-02-29
AU2004216559B2 (en) 2010-05-27
AU2004216559A1 (en) 2004-09-10
JP4688787B2 (en) 2011-05-25
KR101136573B1 (en) 2012-04-23
WO2004075875A8 (en) 2004-12-29
MXPA05009079A (en) 2006-05-19

Similar Documents

Publication Publication Date Title
HK1089083A1 (en) Dosage form having a saccharide matrix
EG27104A (en) Pharmaceutical compounds
ZA200606229B (en) A pharmaceutical composition
GB0308511D0 (en) Pharmaceutical compounds
GB0526180D0 (en) N/a
EP1625160A4 (en) A bioelastomer
GB2397327B (en) A screwpile
GB0314733D0 (en) Medicaments
GB0400452D0 (en) A pharmaceutical composition
AU2003291758A8 (en) Waxy matrix dosage forms
GB0301736D0 (en) Pharmaceutical compounds
GB0313766D0 (en) Pharmaceutical compounds
GB0526009D0 (en) N/a
GB0327282D0 (en) A blanket
AU156151S (en) Stamp
HRP20020648A2 (en) Racket-raster matrix
AU154450S (en) A plate
ZA200402034B (en) A pharmaceutical composition.
GB0315019D0 (en) Dosage form
GB0329994D0 (en) A novel medicament
TW584357U (en) A dial-switch
AU155132S (en) Stamp
AU157680S (en) A plate
AU157679S (en) A plate
AU157681S (en) A plate